IntrinsicIntrinsic
← Scroll for more →

Financial Statements — IPHYF

Balance Sheet

(in millions EUR)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents28.0953.7066.4069.9970.6171.4184.23102.95103.76103.98
Total Current Assets46.7164.9885.74111.59148.01144.46139.83171.80138.26129.69
Total Non-current Assets16.0127.9625.3239.9036.1854.5968.03108.63129.24136.53
Total Assets62.7292.94111.06151.50184.19199.05207.86280.43267.50266.22
Total Current Liabilities36.6529.4332.9838.2239.6437.6741.3473.5679.8942.62
Total Non-current Liabilities47.7758.3769.2484.4892.66103.52112.3790.5480.1790.04
Total Liabilities*84.4287.79102.23122.70132.29141.19153.71164.10160.06132.66
Total Stockholder Equity(21.70)5.148.8328.8051.9057.8654.15116.33107.44133.56
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions EUR) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Total Revenue4.8612.3540.2045.5915.69
Research & Development20.5229.0831.4524.9621.79
Selling, General & Admin9.779.589.1412.1419.32
Total Operating Expenses30.2938.6640.6037.1041.12
Operating Income(25.43)(26.31)(0.40)8.49(25.43)
Interest Expense0.230.300.320.190.16
Pretax Income(21.34)(24.76)1.726.38(23.72)
Tax Provision0.000.000.000.000.00
Net Income(21.34)(24.76)1.726.30(23.72)
Basic EPS(0.25)(0.31)0.020.08(0.30)
Diluted EPS(0.25)(0.31)0.020.08(0.30)
← Scroll for more columns →

Cash Flow Statement

(in millions EUR)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow(31.16)3.04(11.46)1.22(31.16)
Investing Cash Flow6.970.93(0.25)(0.39)(0.25)
Financing Cash Flow10.48(4.33)(1.25)(0.96)(1.23)
← Scroll for more columns →